Canada Approves New Leaf’s Bid to Build First-Of-Its-Kind Psilocybin Lab
Business
New Leaf Canada has received permission from Health Canada to build a first-of-its-kind laboratory to produce and study psilocybin and psilocin.
Voters in six states have the opportunity to send a pro drug legalization message to Washington DC on cannabis and psychedelics in the midterm elections
Way back in January 2012, I wrote an article previewing what could be an exceptional year for drug policy reform because of Colorado and Washington State's opportunity to be the first states to legalize marijuana for recreational use —which voters of course did. While you didn't have to be Nostradamus to sense that something big might be in play for drug policy reform, when we fast forward a decade since, another 17 states have now legalized recreational marijuana. And so, sure, while 2012 was indeed an exceptional year for drug policy reform, clearly, it was only getting started.
Once again, voters in five states will have the opportunity to legalize drugs in some way. In the upcoming November elections marijuana legalization is on the ballot in Maryland, Missouri, Arkansas, South Dakota, and North Dakota. And voters in Colorado will have the chance to be the first state to legalize possession of psychedelics and allow psychedelic assisted therapy for adults.
Here’s a quick breakdown of those initiatives and the most recent available polling data.
Maryland aside, no other initiative is polling significantly out in front. Arkansas, Colorado, and Missouri all look like toss ups that could go either way, while it seems the Dakota's are leaning against. As we've recently seen, polling and public opinion surveys certainly have their limitations, so we’ll just have to wait and see what voters do on election day. But at the very least, it looks like we'll have a 20th state with legal cannabis. Watch this space for a follow up post to see how these initiatives do with voters, as well as more criminal legal and drug policy analysis.
Brad R. Schlesinger, Esq is a criminal lawyer, drug policy analyst, and PSYC Advisory Board member.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
Leave a Reply
Want to join the discussion?Feel free to contribute!